OraSure issued new oral fluid patent

Published: 3-Feb-2004

OraSure Technologies has received notice from the US patent and trademark office that a new patent will be issued with broad claims covering a lateral flow diagnostic test that can be used to test oral fluid or other specimen types for the presence of one or more antibodies or other analytes. The patent's claims will cover the company's current OraQuick Rapid HIV-1 antibody test.


OraSure Technologies has received notice from the US patent and trademark office that a new patent will be issued with broad claims covering a lateral flow diagnostic test that can be used to test oral fluid or other specimen types for the presence of one or more antibodies or other analytes. The patent's claims will cover the company's current OraQuick Rapid HIV-1 antibody test.

'We are pleased to receive such a significant patent that will contain claims broadly covering rapid, point-of-care diagnostic tests on a lateral flow format,' said Mike Gausling, president and ceo of OraSure Technologies. 'We are committed to broadening the reach of our patent portfolio and in particular our intellectual property related to our core technologies for oral fluid collection and testing. We look forward to continuing to build our intellectual property position as we expand into new applications and develop new products.'

OraSure currently maintains a substantial patent portfolio relating to its oral fluid products and technologies, including 16 U.S. patents and numerous foreign patents for its OraSure and Intercept oral fluid collection devices and related technology. In addition, OraSure holds or has licensed rights to an additional 16 US patents and numerous foreign patents relating to its up-converting phosphor technology, including the first application of UPT, the company's UPlink oral fluid rapid drug detection system.

See more

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

Read more
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Medical Devices

Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Subscribe now